|
INKT Mink Therapeutics Inc 1840229 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-2,742,368.00 |
| Balance Sheet |
|
Current Assets
|
$10,022,454.00 |
|
Assets
|
$10,376,972.00 |
|
Current Liabilities
|
$7,287,425.00 |
|
Equity
|
$-12,685,989.00 |
|
Shares Out
|
3963045.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-1,732,597.00 |
|
Investing Cash Flow
|
$-73,561.00 |
| Market Analysis |
Market Cap
|
$41,968,646.55 |
|
Price
|
$10.52 |
|
PB
|
4.57 |
|
EPS
|
-0.57 |
|
FCF
|
$-1,806,158.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:39 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:38 |
|
| Apr |
May |
Jun |
| 2026-03-31 |
-0.56 |
|
|
2026-05-15 |
-0.57 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-14 |
-1.06 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-14 |
-0.65 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view INKT documents filed with the SEC.
INKT Filings
Clear
